LIVEN results Liven Pharma Limited
Liven Pharma Limited (LIVEN) has 10 results with figures on file. Quarter ended 30 Sep 2026: earnings per share Rs -0.07, sales Rs 14.3 m. The next results are expected between 14 Oct 2026 and 13 Nov 2026 (a projection, not an announced date).
One line for each result
- Quarter ended 30 Sep 2026: earnings per share Rs -0.07, sales Rs 14.3 m.
- Year ended 30 Jun 2026: earnings per share Rs -0.28, sales Rs 105.8 m.
- Quarter ended 31 Mar 2026: earnings per share Rs -0.03, sales Rs 29.2 m.
- Quarter ended 31 Dec 2025: earnings per share Rs -0.30, sales Rs 54.6 m.
- Quarter ended 30 Sep 2025: earnings per share Rs -0.28, sales Rs 8.8 m.
- Year ended 30 Jun 2025: earnings per share Rs -7.11 (as filed; the share count is not explained by a confirmed action), sales Rs 127.3 m.
- Quarter ended 31 Mar 2025: earnings per share Rs -0.10, sales Rs 14.8 m.
- Year ended 30 Jun 2024: earnings per share Rs 1.04 (as filed; the share count is not explained by a confirmed action), sales Rs 245.1 m.
- Year ended 30 Jun 2023: earnings per share Rs -1.02 (as filed; the share count is not explained by a confirmed action).
- Year ended 30 Jun 2022: earnings per share Rs -1.18 (as filed; the share count is not explained by a confirmed action).
Written from the figures below. Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later.
When the next results are due
Next results
Quarterly results, to 30 Sep 2026: expected between 14 Oct 2026 and 13 Nov 2026.
A projection, not an announced date. An estimate from the usual timing across the market; this company has no earlier filings on record.
Results dates on record
| Date | What | Status |
|---|---|---|
| 14 Oct 2026 | Quarterly results expected between 14 Oct 2026 and 13 Nov 2026 | Expected window, not an announced date |
| 5 Oct 2026 | Full-year results, to 30 Jun 2026 | Filed with the exchange |
Source: the exchange’s results announcements. An expected window is an estimate from the dates of earlier filings.
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | -0.07 | Rs 14.3 m | Rs -7.4 m | -51.6% | — |
| Quarter to 31 Mar 2026 | -0.03 | Rs 29.2 m | Rs -4.0 m | -13.5% | — |
| Quarter to 31 Dec 2025 | -0.30 | Rs 54.6 m | Rs 28.2 m | 51.7% | — |
| Quarter to 30 Sep 2025 | -0.28 | Rs 8.8 m | Rs -30.2 m | -341.9% | — |
| Quarter to 31 Mar 2025 | -0.10 | Rs 14.8 m | Rs -9.6 m | -65.2% | — |
Results filings at the exchange
| Date | Filing | Kind | |
|---|---|---|---|
| 2 Nov 2026 | Financial Results for the Quarter Ended September 30-2026 | Quarterly accounts | |
| 5 Oct 2026 | financial results for the Year Ended June 30, 2026 | Financial results | |
| 29 Apr 2026 | Financial Results for the 3rd Quarter Ended 31st March 2026 | Quarterly accounts | |
| 27 Feb 2026 | Financial Results for the half year ended December 31, 2025 | Half-yearly accounts | |
| 2 Jan 2026 | Financial results for the quarter ended September 30, 2025. | Quarterly accounts | |
| 31 Dec 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Dec 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Mar 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Mar 2025 | Quarterly report 2025 | Quarterly accounts |
9 filings stored.
More on LIVEN
- LIVEN share price and overview
- Pharmaceuticals sector
- MACTER results · Macter International Limited
- OTSU results · Otsuka Pakistan Limited
- GLAXO results · GlaxoSmithKline Pakistan Limited
- ABOT results · Abbott Laboratories (Pakistan) Limited
- HALEON results · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .